Compartment-specific control of reactive oxygen species scavenging by antioxidant pathway enzymes

Journal of Biological Chemistry

Volumn 291, Issue 21, 2016, Pages 11185-11197

  Dey, Swati ^a   Sidor, Agnieszka ^a   O'Rourke, Brian ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANTS; ENZYMES; GENE TRANSFER; MITOCHONDRIA; MOLECULAR BIOLOGY; OXYGEN; PEPTIDES; REDOX REACTIONS;

ANTIOXIDANT ENZYME; CARDIO-VASCULAR DISEASE; GENETIC MANIPULATIONS; INTRACELLULAR COMPARTMENTS; MITOCHONDRIAL SUBSTRATES; RATE-CONTROLLING STEPS; REACTIVE OXYGEN SPECIES; SCAVENGING ENZYMES;

SCAVENGING;

ANTIOXIDANT; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GREEN FLUORESCENT PROTEIN; HYDROGEN PEROXIDE; ISOCITRATE DEHYDROGENASE 2; PEROXIDASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; THIOREDOXIN REDUCTASE; VIRUS VECTOR; SCAVENGER;

ANIMAL CELL; ARTICLE; CARDIAC MYOBLAST; CATABOLISM; CELL LINE; CONTROLLED STUDY; CYTOSOL; GENE TRANSFER; GENETIC MANIPULATION; GENETIC TRANSDUCTION; H9C2 CELL LINE; MITOCHONDRION; NONHUMAN; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; ANIMAL; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; OXIDATION REDUCTION REACTION;

ANIMALS; CELL LINE; FREE RADICAL SCAVENGERS; HYDROGEN PEROXIDE; MITOCHONDRIA; MYOBLASTS, CARDIAC; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS;

EID: 84971426673     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M116.726968     Document Type: Article

References (67)

1. Burgoyne, J. R., Mongue-Din, H., Eaton, P., and Shah, A. M. (2012) Redox signaling in cardiac physiology and pathology. Circ. Res. 111, 1091-1106
2. Santos, C. X., Anilkumar, N., Zhang, M., Brewer, A. C., and Shah, A. M. (2011) Redox signaling in cardiac myocytes. Free Radic. Biol. Med. 50, 777-793
3. Zima, A. V., and Blatter, L. A. (2006) Redox regulation of cardiac calcium channels and transporters. Cardiovasc. Res. 71, 310-321
4. Lee, M. Y., and Griendling, K. K. (2008) Redox signaling, vascular function, and hypertension. Antioxid. Redox Signal. 10, 1045-1059
5. Balaban, R. S., Nemoto, S., and Finkel, T. (2005) Mitochondria, oxidants, and aging. Cell 120, 483-495
6. Roe, N. D., and Ren, J. (2012) Nitric oxide synthase uncoupling: a therapeutic target in cardiovascular diseases. Vascul. Pharmacol. 57, 168-172
7. Cappola, T. P., Kass, D. A., Nelson, G. S., Berger, R. D., Rosas, G. O., Kobeissi, Z. A., Marbán, E., and Hare, J. M. (2001) Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 104, 2407-2411
8. Kaludercic, N., Carpi, A., Nagayama, T., Sivakumaran, V., Zhu, G., Lai, E. W., Bedja, D., De Mario, A., Chen, K., Gabrielson, K. L., Lindsey, M. L., Pacak, K., Takimoto, E., Shih, J. C., Kass, D. A., et al. (2014) Monoamine oxidase B prompts mitochondrial and cardiac dysfunction in pressure overloaded hearts. Antioxid. Redox Signal. 20, 267-280
9. Kaludercic, N., Takimoto, E., Nagayama, T., Feng, N., Lai, E. W., Bedja, D., Chen, K., Gabrielson, K. L., Blakely, R. D., Shih, J. C., Pacak, K., Kass, D. A., Di Lisa, F., and Paolocci, N. (2010) Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload. Circ. Res. 106, 193-202
10. Yang, K. C., Kyle, J. W., Makielski, J. C., and Dudley, S. C., Jr. (2015) Mechanisms of sudden cardiac death: oxidants and metabolism. Circ. Res. 116, 1937-1955
11. q overexpression-induced heart failure. Circ. Res. 108, 837-846
12. Dai, D. F., Santana, L. F., Vermulst, M., Tomazela, D. M., Emond, M. J., MacCoss, M. J., Gollahon, K., Martin, G. M., Loeb, L. A., Ladiges, W. C., and Rabinovitch, P. S. (2009) Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging. Circulation 119, 2789-2797
13. Wardman, P. (2007) Fluorescent and luminescent probes for measurement of oxidative and nitrosative species in cells and tissues: progress, pitfalls, and prospects. Free Radic. Biol. Med. 43, 995-1022
14. Winterbourn, C. C. (2014) The challenges of using fluorescent probes to detect and quantify specific reactive oxygen species in living cells. Biochim. Biophys. Acta 1840, 730-738
15. Meyer, A. J., and Dick, T. P. (2010) Fluorescent protein-based redox probes. Antioxid. Redox Signal. 13, 621-650
16. 2 with roGFP2-based redox probes. Free Radic. Biol. Med. 51, 1943-1951
17. 2 -scavenging peroxidases. J. Biol. Chem. 284, 31532-31540
18. Kortylewski, M., Swiderski, P., Herrmann, A., Wang, L., Kowolik, C., Kujawski, M., Lee, H., Scuto, A., Liu, Y., Yang, C., Deng, J., Soifer, H. S., Raubitschek, A., Forman, S., Rossi, J. J., et al. (2009) In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses. Nat. Biotechnol. 27, 925-932
19. Kim, D. H., Behlke, M. A., Rose, S. D., Chang, M. S., Choi, S., and Rossi, J. J. (2005) Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Nat. Biotechnol. 23, 222-226
20. Kelner, M. J., and Montoya, M. A. (2000) Structural organization of the human glutathione reductase gene: determination of correct cDNA sequence and identification of a mitochondrial leader sequence. Biochem. Biophys. Res. Commun. 269, 366-368
21. Hoek, J. B., and Rydström, J. (1988) Physiological roles of nicotinamide nucleotide transhydrogenase. Biochem. J. 254, 1-10
22. Zhang, H., Go, Y. M., and Jones, D. P. (2007) Mitochondrial thioredoxin-2/peroxiredoxin-3 system functions in parallel with mitochondrial GSH system in protection against oxidative stress. Arch. Biochem. Biophys. 465, 119-126
23. Cox, A. G., Winterbourn, C. C., and Hampton, M. B. (2010) Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling. Biochem. J. 425, 313-325
24. Garcia, J., Han, D., Sancheti, H., Yap, L. P., Kaplowitz, N., and Cadenas, E. (2010) Regulation of mitochondrial glutathione redox status and protein glutathionylation by respiratory substrates. J. Biol. Chem. 285, 39646-39654
25. Schafer, F. Q., and Buettner, G. R. (2001) Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med. 30, 1191-1212
26. 2 emission: an experimental-computational study. J. Gen. Physiol. 139, 479-491
27. 2 detoxification of rat brain mitochondria. Biochim Biophys Acta 1817, 1901-1906
28. Zhang, J., Cui, X., Wang, L., Liu, F., Jiang, T., Li, C., Li, D., Huang, M., Liao, S., Wang, J., Chen, J., Jia, H., He, J., Tang, Z., Yin, Z., et al. (2014) The mitochondrial thioredoxin is required for liver development in zebrafish. Curr. Mol. Med. 14, 772-782
29. Wu, C., Jain, M. R., Li, Q., Oka, S., Li, W., Kong, A. N., Nagarajan, N., Sadoshima, J., Simmons, W. J., and Li, H. (2014) Identification of novel nuclear targets of human thioredoxin 1. Mol. Cell. Proteomics 13, 3507-3518
30. Wu, C., Parrott, A. M., Liu, T., Jain, M. R., Yang, Y., Sadoshima, J., and Li, H. (2011) Distinction of thioredoxin transnitrosylation and denitrosylation target proteins by the ICAT quantitative approach. J. Proteomics 74, 2498-2509
31. Nonn, L., Williams, R. R., Erickson, R. P., and Powis, G. (2003) The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice. Mol. Cell. Biol. 23, 916-922
32. Conrad, M., Jakupoglu, C., Moreno, S. G., Lippl, S., Banjac, A., Schneider, M., Beck, H., Hatzopoulos, A. K., Just, U., Sinowatz, F., Schmahl, W., Chien, K. R., Wurst, W., Bornkamm, G. W., and Brielmeier, M. (2004) Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function. Mol. Cell. Biol. 24, 9414-9423
33. Yamamoto, M., Yang, G., Hong, C., Liu, J., Holle, E., Yu, X., Wagner, T., Vatner, S. F., and Sadoshima, J. (2003) Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy. J. Clin. Invest. 112, 1395-1406
34. Lee, S., Kim, S. M., and Lee, R. T. (2013) Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance. Antioxid. Redox Signal. 18, 1165-1207
35. Brown, K. K., Eriksson, S. E., Arnér, E. S., and Hampton, M. B. (2008) Mitochondrial peroxiredoxin 3 is rapidly oxidized in cells treated with isothiocyanates. Free Radic. Biol. Med. 45, 494-502
36. Cox, A. G., Brown, K. K., Arner, E. S., and Hampton, M. B. (2008) The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation. Biochem. Pharmacol. 76, 1097-1109
37. Peskin, A. V., Dickerhof, N., Poynton, R. A., Paton, L. N., Pace, P. E., Hampton, M. B., and Winterbourn, C. C. (2013) Hyperoxidation of peroxiredoxins 2 and 3: rate constants for the reactions of the sulfenic acid of the peroxidatic cysteine. J. Biol. Chem. 288, 14170-14177
38. Kumar, V., Kitaeff, N., Hampton, M. B., Cannell, M. B., and Winterbourn, C. C. (2009) Reversible oxidation of mitochondrial peroxiredoxin 3 in mouse heart subjected to ischemia and reperfusion. FEBS Lett. 583, 997-1000
39. + -dependent isocitrate dehydrogenase. J. Biol. Chem. 276, 16168-16176
40. Ronchi, J. A., Figueira, T. R., Ravagnani, F. G., Oliveira, H. C., Vercesi, A. E., and Castilho, R. F. (2013) A spontaneous mutation in the nicotinamide nucleotide transhydrogenase gene of C57BL/6J mice results in mitochondrial redox abnormalities. Free Radic. Biol. Med. 63, 446-456
41. Kim, A., Chen, C. H., Ursell, P., and Huang, T. T. (2010) Genetic modifier of mitochondrial superoxide dismutase-deficient mice delays heart failure and prolongs survival. Mamm. Genome 21, 534-542
42. Rydström, J. (2006) Mitochondrial NADPH, transhydrogenase and disease. Biochim. Biophys. Acta 1757, 721-726
43. Radi, R., Turrens, J. F., Chang, L. Y., Bush, K. M., Crapo, J. D., and Freeman, B. A. (1991) Detection of catalase in rat heart mitochondria. J. Biol. Chem. 266, 22028-22034
44. Nelson, S. K., Bose, S. K., Grunwald, G. K., Myhill, P., and McCord, J. M. (2006) The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy. Free Radic. Biol. Med. 40, 341-347
45. q-overexpressing transgenic mice. Circ. Heart Fail. 3, 306-313
46. Schriner, S. E., Linford, N. J., Martin, G. M., Treuting, P., Ogburn, C. E., Emond, M., Coskun, P. E., Ladiges, W., Wolf, N., Van Remmen, H., Wallace, D. C., and Rabinovitch, P. S. (2005) Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 308, 1909-1911
47. Palmieri, F. (2004) The mitochondrial transporter family (SLC25): physiological and pathological implications. Pflugers Arch 447, 689-709
48. Fu, Y., Cheng, W.-H., Porres, J. M., Ross, D. A., and Lei, X. G. (1999) Knockout of cellular glutathione peroxidase gene renders mice susceptible to diquat-induced oxidative stress. Free Radic. Biol. Med. 27, 605-611
49. García-Ruiz, C., Colell, A., Morales, A., Kaplowitz, N., and Fernández-Checa, J. C. (1995) Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-κB: studies with isolated mitochondria and rat hepatocytes. Mol. Pharmacol. 48, 825-834
50. Aon, M. A., Cortassa, S., Maack, C., and O'Rourke, B. (2007) Sequential opening of mitochondrial ion channels as a function of glutathione redox thiol status. J. Biol. Chem. 282, 21889-21900
51. Blair, I. A. (2006) Endogenous glutathione adducts. Curr. Drug Metab. 7, 853-872
52. Valko, M., Morris, H., and Cronin, M. T. (2005) Metals, toxicity and oxidative stress. Curr. Med. Chem. 12, 1161-1208
53. Aon, M. A., Cortassa, S., and O'Rourke, B. (2010) Redox-optimized ROS balance: a unifying hypothesis. Biochim. Biophys. Acta 1797, 865-877
54. Calabrese, E. J., Bachmann, K. A., Bailer, A. J., Bolger, P. M., Borak, J., Cai, L., Cedergreen, N., Cherian, M. G., Chiueh, C. C., Clarkson, T. W., Cook, R. R., Diamond, D. M., Doolittle, D. J., Dorato, M. A., Duke, S. O., et al. (2007) Biological stress response terminology: Integrating the concepts of adaptive response and preconditioning stress within a hormetic doseresponse framework. Toxicol. Appl. Pharmacol. 222, 122-128
55. Suvorova, E. S., Lucas, O., Weisend, C. M., Rollins, M. F., Merrill, G. F., Capecchi, M. R., and Schmidt, E. E. (2009) Cytoprotective Nrf2 pathway is induced in chronically txnrd 1-deficient hepatocytes. PLoS ONE 4, e6158
56. Heart Protection Study Collaborative Group (2002) MRC/BHF heart protection study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360, 23-33
57. Steinhubl, S. R. (2008) Why have antioxidants failed in clinical trials? Am. J. Cardiol. 101, 14D-19D
58. Stephens, N. G., Parsons, A., Schofield, P. M., Kelly, F., Cheeseman, K., and Mitchinson, M. J. (1996) Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347, 781-786
59. Tepel, M., van der Giet, M., Statz, M., Jankowski, J., and Zidek, W. (2003) The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial. Circulation 107, 992-995
60. Yusuf, S., Dagenais, G., Pogue, J., Bosch, J., and Sleight, P. (2000) Vitamin E supplementation and cardiovascular events in high-risk patients: The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 342, 154-160
61. 2+; exchange prevents sudden death in a guinea pig model of heart failure. Circ. Res. 115, 44-54
62. Kelso, G. F., Porteous, C. M., Coulter, C. V., Hughes, G., Porteous, W. K., Ledgerwood, E. C., Smith, R. A., and Murphy, M. P. (2001) Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J. Biol. Chem. 276, 4588-4596
63. Skulachev, V. P., Anisimov, V. N., Antonenko, Y. N., Bakeeva, L. E., Chernyak, B. V., Erichev, V. P., Filenko, O. F., Kalinina, N. I., Kapelko, V. I., Kolosova, N. G., Kopnin, B. P., Korshunova, G. A., Lichinitser, M. R., Obukhova, L. A., Pasyukova, E. G., et al. (2009) An attempt to prevent senescence: a mitochondrial approach. Biochim. Biophys. Acta 1787, 437-461
64. Doughan, A. K., and Dikalov, S. I. (2007) Mitochondrial redox cycling of mitoquinone leads to superoxide production and cellular apoptosis. Antioxid. Redox Signal. 9, 1825-1836
65. Szeto, H. H. (2014) First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br. J. Pharmacol. 171, 2029-2050
66. Brown, D. A., Hale, S. L., Baines, C. P., del Rio, C. L., Hamlin, R. L., Yueyama, Y., Kijtawornrat, A., Yeh, S. T., Frasier, C. R., Stewart, L. M., Moukdar, F., Shaikh, S. R., Fisher-Wellman, K. H., Neufer, P. D., and Kloner, R. A. (2014) Reduction of early reperfusion injury with the mitochondriatargeting peptide bendavia. J. Cardiovasc. Pharmacol. Ther. 19, 121-132
67. Birk, A. V., Liu, S., Soong, Y., Mills, W., Singh, P., Warren, J. D., Seshan, S. V., Pardee, J. D., and Szeto, H. H. (2013) The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. J. Am. Soc. Nephrol. 24, 1250-1261